XIAP and prostate carcinoma: A recent study has shown that knockdown of the exosomal circRNA X-linked inhibitor of apoptosis (circXIAP) could restrain cell migration and proliferation, and induce cell apoptosis, leading to docetaxel (DTX) sensitization in prostate cancer cells (Zhang et al., 2021).